Ineos Oxford Institute concludes data collection for two major global AMR studies

The Ineos Oxford Institute for Antimicrobial Research has completed data collection for two major global AMR studies—BARNARDS and BALANCE—representing one of the largest coordinated efforts to understand antimicrobial resistance in low- and middle-income countries. Together, these studies gathered tens of thousands of patient samples and thousands of bacterial isolates from bloodstream infections, enabling detailed microbiological and genomic analyses. The data will generate hospital-, country-, and region-specific insights into resistance patterns, treatment practices, and patient outcomes, particularly for severe conditions such as sepsis, including neonatal infections. By combining clinical, epidemiological, and molecular data, the studies aim to improve antibiotic selection, inform national policies, support drug development, and ultimately enhance patient outcomes, while highlighting the need for tailored, context-specific responses to AMR.